Global Genetic Engineering Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Devices;

PCR, Gene Gun, and Gel Assemblies.

By Techniques;

Artificial Selection, Cloning, Gene Splicing, and Others.

By End User;

Research Institutes, Academic Institutes, Pharmaceutical Industries, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn129175109 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Genetic Engineering Market (USD Million), 2021 - 2031

In the year 2024, the Global Genetic Engineering Market was valued at USD 4,912.49 million. The size of this market is expected to increase to USD 10,361.01 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.3%.

The global genetic engineering market represents a dynamic and rapidly evolving sector at the forefront of biotechnology innovation. Genetic engineering, also known as genetic modification or genetic manipulation, involves the manipulation of an organism's genetic material using biotechnological tools and techniques to achieve specific outcomes. These outcomes may include the creation of genetically modified organisms (GMOs), development of novel gene therapies, production of recombinant proteins, and engineering of agricultural crops with desired traits. The global genetic engineering market encompasses a wide range of applications across diverse sectors, including healthcare, agriculture, industrial biotechnology, and environmental remediation, driving innovation and addressing pressing challenges in human health, food security, and sustainability.

In the healthcare sector, genetic engineering plays a pivotal role in advancing precision medicine, personalized therapeutics, and gene-based therapies for the treatment of genetic disorders, cancer, infectious diseases, and chronic conditions. The advent of genome editing technologies such as CRISPR-Cas9 has revolutionized the field of molecular biology, enabling precise modification of DNA sequences in living organisms and offering unprecedented opportunities for therapeutic intervention and disease prevention. Gene editing tools are being used to develop innovative gene therapies, gene editing-based drugs, and cell-based therapies, providing new avenues for treating previously incurable diseases and improving patient outcomes. Moreover, genetic engineering is driving advancements in diagnostic testing, pharmacogenomics, and biomarker discovery, facilitating early disease detection, targeted drug development, and personalized treatment strategies tailored to individual patient characteristics and genetic makeup.

In the agriculture sector, genetic engineering plays a crucial role in enhancing crop productivity, nutritional quality, and resilience to biotic and abiotic stresses, thereby contributing to global food security and sustainable agriculture. Genetically modified (GM) crops engineered with traits such as herbicide tolerance, insect resistance, and drought tolerance offer farmers cost-effective solutions for pest management, weed control, and resource conservation, reducing reliance on chemical inputs and promoting environmentally sustainable farming practices. Moreover, genetic engineering is enabling the development of biofortified crops with enhanced nutritional profiles, such as vitamin-enriched rice and iron-fortified beans, addressing malnutrition and micronutrient deficiencies in vulnerable populations worldwide. Additionally, genetic engineering techniques are being used to develop disease-resistant livestock, enhance livestock productivity, and improve animal welfare, supporting the livestock industry and ensuring a safe and sustainable food supply.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Devices

    2. Market Snapshot, By Techniques
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Genetic Engineering Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Demand for Genetically Modified Organisms (GMOs)
        2. Growing Application in Biopharmaceuticals and Therapeutics
        3. Expanding Biotechnology and Life Sciences Industry
        4. Rising Focus on Precision Medicine
      2. Restraints
        1. Potential for Off-target Effects in Gene Editing
        2. Limited Understanding of Genetic Mechanisms
        3. High Cost of Genetic Engineering Technologies
        4. Public Perception and Acceptance
      3. Opportunities
        1. Expansion into Agricultural Biotechnology
        2. Integration of Gene Editing in Drug Discovery
        3. Collaboration with Academic and Research Institutions
        4. Focus on Synthetic Biology and Gene Synthesis
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Genetic Engineering Market, By Devices, 2021 - 2031 (USD Million)
      1. PCR
      2. Gene Gun
      3. Gel Assemblies
    2. Global Genetic Engineering Market, By Techniques, 2021 - 2031 (USD Million)
      1. Artificial Selection
      2. Cloning
      3. Gene Splicing
      4. Others
    3. Global Genetic Engineering Market, By End User, 2021 - 2031 (USD Million)
      1. Research Institutes
      2. Academic Institutes
      3. Pharmaceutical Industries
      4. Others
    4. Global Genetic Engineering Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific Inc
      2. GenScript
      3. Amgen Inc
      4. Genentech
      5. Merck KGaA
      6. Horizon Discovery Group plc
      7. Sangamo Therapeutics
      8. Transposagen Biopharmaceuticals
      9. OriGene Technologies
  7. Analyst Views
  8. Future Outlook of the Market